CD96 (Cluster of Differentiation 96) or Tactile (T cell activation, increased late expression) is a protein that in humans is encoded by the CD96gene.[5] CD96 is a receptor protein which is expressed on T cells and NK cells and shares sequence similarity with CD226 (also known as DNAM-1).[6] The protein encoded by this gene belongs to the immunoglobulin superfamily. It is a type I membrane protein. The protein may play a role in the adhesion of activated T and NK cells to their target cells during the late phase of the immune response. It may also function in antigen presentation[citation needed]. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified. CD96 is a transmembrane glycoprotein that has three extracellular immunoglobulin-like domains and is expressed by all resting human and mouse NK cells. CD96 main ligand is CD155. CD 96 has approximately 20% homology with CD226 and competed for binding to CD155 with CD226.[7]
The protein encoded by this gene belongs to the immunoglobulin superfamily. It is a type I membrane protein. The protein may play a role in the adhesive interactions of activated T and NK cells during the late phase of the immune response. It may also function in antigen presentation. Alternative splicing generates multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2016].
^Fuchs A, Colonna M (October 2006). "The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance". Seminars in Cancer Biology. 16 (5): 359–366. doi:10.1016/j.semcancer.2006.07.002. PMID16904340.359-366&rft.date=2006-10&rft_id=info:doi/10.1016/j.semcancer.2006.07.002&rft_id=info:pmid/16904340&rft.aulast=Fuchs&rft.aufirst=A&rft.au=Colonna, M&rfr_id=info:sid/en.wikipedia.org:CD96" class="Z3988">
Hosen N, Park CY, Tatsumi N, Oji Y, Sugiyama H, Gramatzki M, et al. (June 2007). "CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia". Proceedings of the National Academy of Sciences of the United States of America. 104 (26): 11008–11013. Bibcode:2007PNAS..10411008H. doi:10.1073/pnas.0704271104. PMC1904175. PMID17576927.11008-11013&rft.date=2007-06&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904175#id-name=PMC&rft_id=info:pmid/17576927&rft_id=info:doi/10.1073/pnas.0704271104&rft_id=info:bibcode/2007PNAS..10411008H&rft.aulast=Hosen&rft.aufirst=N&rft.au=Park, CY&rft.au=Tatsumi, N&rft.au=Oji, Y&rft.au=Sugiyama, H&rft.au=Gramatzki, M&rft.au=Krensky, AM&rft.au=Weissman, IL&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904175&rfr_id=info:sid/en.wikipedia.org:CD96" class="Z3988">
Kaname T, Yanagi K, Chinen Y, Makita Y, Okamoto N, Maehara H, et al. (October 2007). "Mutations in CD96, a member of the immunoglobulin superfamily, cause a form of the C (Opitz trigonocephaly) syndrome". American Journal of Human Genetics. 81 (4): 835–841. doi:10.1086/522014. PMC2227933. PMID17847009.835-841&rft.date=2007-10&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2227933#id-name=PMC&rft_id=info:pmid/17847009&rft_id=info:doi/10.1086/522014&rft.aulast=Kaname&rft.aufirst=T&rft.au=Yanagi, K&rft.au=Chinen, Y&rft.au=Makita, Y&rft.au=Okamoto, N&rft.au=Maehara, H&rft.au=Owan, I&rft.au=Kanaya, F&rft.au=Kubota, Y&rft.au=Oike, Y&rft.au=Yamamoto, T&rft.au=Kurosawa, K&rft.au=Fukushima, Y&rft.au=Bohring, A&rft.au=Opitz, JM&rft.au=Yoshiura, K&rft.au=Niikawa, N&rft.au=Naritomi, K&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2227933&rfr_id=info:sid/en.wikipedia.org:CD96" class="Z3988">
Meyer D, Seth S, Albrecht J, Maier MK, du Pasquier L, Ravens I, et al. (January 2009). "CD96 interaction with CD155 via its first Ig-like domain is modulated by alternative splicing or mutations in distal Ig-like domains". The Journal of Biological Chemistry. 284 (4): 2235–2244. doi:10.1074/jbc.M807698200. PMID19056733.2235-2244&rft.date=2009-01&rft_id=info:doi/10.1074/jbc.M807698200&rft_id=info:pmid/19056733&rft.aulast=Meyer&rft.aufirst=D&rft.au=Seth, S&rft.au=Albrecht, J&rft.au=Maier, MK&rft.au=du Pasquier, L&rft.au=Ravens, I&rft.au=Dreyer, L&rft.au=Burger, R&rft.au=Gramatzki, M&rft.au=Schwinzer, R&rft.au=Kremmer, E&rft.au=Foerster, R&rft.au=Bernhardt, G&rft_id=https://doi.org/10.1074%2Fjbc.M807698200&rfr_id=info:sid/en.wikipedia.org:CD96" class="Z3988">
Davila S, Froeling FE, Tan A, Bonnard C, Boland GJ, Snippe H, et al. (April 2010). "New genetic associations detected in a host response study to hepatitis B vaccine". Genes and Immunity. 11 (3): 232–238. doi:10.1038/gene.2010.1. PMID20237496. S2CID11183658.232-238&rft.date=2010-04&rft_id=https://api.semanticscholar.org/CorpusID:11183658#id-name=S2CID&rft_id=info:pmid/20237496&rft_id=info:doi/10.1038/gene.2010.1&rft.aulast=Davila&rft.aufirst=S&rft.au=Froeling, FE&rft.au=Tan, A&rft.au=Bonnard, C&rft.au=Boland, GJ&rft.au=Snippe, H&rft.au=Hibberd, ML&rft.au=Seielstad, M&rfr_id=info:sid/en.wikipedia.org:CD96" class="Z3988">
Wu Y, Xiao M, Zhu L, Zhou XX, Gong Q, Xin X, et al. (June 2011). "[CD96 expression on bone marrow mononuclear cells in 91 patients with acute leukemia]". Zhongguo Shi Yan Xue Ye Xue Za Zhi (in Chinese). 19 (3): 585–588. PMID21729528.585-588&rft.date=2011-06&rft_id=info:pmid/21729528&rft.aulast=Wu&rft.aufirst=Y&rft.au=Xiao, M&rft.au=Zhu, L&rft.au=Zhou, XX&rft.au=Gong, Q&rft.au=Xin, X&rft.au=Li, CR&rft.au=Zhou, JF&rft.au=Deng, JN&rfr_id=info:sid/en.wikipedia.org:CD96" class="Z3988">
Chávez-González A, Dorantes-Acosta E, Moreno-Lorenzana D, Alvarado-Moreno A, Arriaga-Pizano L, Mayani H (May 2014). "Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia". Archives of Medical Research. 45 (4): 343–350. doi:10.1016/j.arcmed.2014.04.001. PMID24751333.343-350&rft.date=2014-05&rft_id=info:doi/10.1016/j.arcmed.2014.04.001&rft_id=info:pmid/24751333&rft.aulast=Chávez-González&rft.aufirst=A&rft.au=Dorantes-Acosta, E&rft.au=Moreno-Lorenzana, D&rft.au=Alvarado-Moreno, A&rft.au=Arriaga-Pizano, L&rft.au=Mayani, H&rfr_id=info:sid/en.wikipedia.org:CD96" class="Z3988">